Metastatic Colorectal Cancers Completed Phase 1 Trials for Irinotecan (DB00762)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02069704Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTINĀ®) in First-line Treatment mCRC PatientsTreatment
NCT01183494A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsTreatment
NCT02641873A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal CancerTreatment
NCT00563316Effect of Panitumumab on the Pharmacokinetics of IrinotecanTreatment
NCT01124630Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other TreatmentsTreatment